世界の眼科治療薬市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Ophthalmic Therapeutic Drugs Market Size, Status and Forecast 2021-2027

• レポートコード：QYR2104Z4274 • 出版社/出版日：QYResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、93ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療

• 販売価格（消費税別）

Single User	￥546,000 (USD3,900)	▷ お問い合わせ
Multi User/Five User	￥819,000 (USD5,850)	▷ お問い合わせ
Enterprise License（同一法人内共有可）	￥1,092,000 (USD7,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

QYResearch社発行の本調査資料では、眼科治療薬のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（抗炎症薬、抗感染薬、抗緑内障薬、抗アレルギー薬、抗VEGF薬、その他）、用途別市場規模（病院薬局、オンライン薬局、独立型薬局＆ドラッグストア）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。 ・市場概要 ・眼科治療薬の市場動向 ・企業の競争状況、市場シェア ・眼科治療薬の種類別市場規模（抗炎症薬、抗感染薬、抗緑内障薬、抗アレルギー薬、抗VEGF薬、その他） ・眼科治療薬の用途別市場規模（病院薬局、オンライン薬局、独立型薬局＆ドラッグストア） ・眼科治療薬の北米市場規模2016-2027（アメリカ、カナダ） ・眼科治療薬のヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等） ・眼科治療薬のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・眼科治療薬の中南米市場規模2016-2027（メキシコ、ブラジル） ・眼科治療薬の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Bayer、Pfizer、Novartis、ALLERGAN、Aerie Pharmaceuticals、Bausch Health、Genentech、Regeneron Pharmaceuticals、Takeda、Santen Pharmaceutical） ・結論

Market Analysis and Insights: Global Ophthalmic Therapeutic Drugs Market
The global Ophthalmic Therapeutic Drugs market size is projected to reach US$ 22640 million by 2026, from US$ 15860 million in 2019, at a CAGR of 5.2% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Ophthalmic Therapeutic Drugs market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Ophthalmic Therapeutic Drugs market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Ophthalmic Therapeutic Drugs market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Ophthalmic Therapeutic Drugs market.

Global Ophthalmic Therapeutic Drugs Scope and Market Size
Ophthalmic Therapeutic Drugs market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Ophthalmic Therapeutic Drugs market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Anti-inflammatory Drugs
Anti-infective Drugs
Anti-glaucoma Drugs
Anti-allergy Drugs
Anti-VEGF Agents
Others

Segment by Application
Hospital Pharmacies
Online Pharmacies
Independent Pharmacies & Drug Stores

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Bayer
Pfizer
Novartis
ALLERGAN
Aerie Pharmaceuticals
Bausch Health
Genentech
Regeneron Pharmaceuticals
Takeda

レポート目次

---

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Ophthalmic Therapeutic Drugs Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Anti-inflammatory Drugs
1.2.3 Anti-infective Drugs
1.2.4 Anti-glaucoma Drugs
1.2.5 Anti-allergy Drugs
1.2.6 Anti-VEGF Agents
1.2.7 Others
1.3 Market by Application
1.3.1 Global Ophthalmic Therapeutic Drugs Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospital Pharmacies
1.3.3 Online Pharmacies
1.3.4 Independent Pharmacies & Drug Stores
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Ophthalmic Therapeutic Drugs Market Perspective (2016-2027)
2.2 Ophthalmic Therapeutic Drugs Growth Trends by Regions
2.2.1 Ophthalmic Therapeutic Drugs Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Ophthalmic Therapeutic Drugs Historic Market Share by Regions (2016-2021)
2.2.3 Ophthalmic Therapeutic Drugs Forecasted Market Size by Regions (2022-2027)
2.3 Ophthalmic Therapeutic Drugs Industry Dynamic
2.3.1 Ophthalmic Therapeutic Drugs Market Trends
2.3.2 Ophthalmic Therapeutic Drugs Market Drivers
2.3.3 Ophthalmic Therapeutic Drugs Market Challenges
2.3.4 Ophthalmic Therapeutic Drugs Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Ophthalmic Therapeutic Drugs Players by Revenue
3.1.1 Global Top Ophthalmic Therapeutic Drugs Players by Revenue (2016-2021)
3.1.2 Global Ophthalmic Therapeutic Drugs Revenue Market Share by Players (2016-2021)
3.2 Global Ophthalmic Therapeutic Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Ophthalmic Therapeutic Drugs Revenue
3.4 Global Ophthalmic Therapeutic Drugs Market Concentration Ratio
3.4.1 Global Ophthalmic Therapeutic Drugs Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Ophthalmic Therapeutic Drugs Revenue in 2020
3.5 Ophthalmic Therapeutic Drugs Key Players Head office and Area Served
3.6 Key Players Ophthalmic Therapeutic Drugs Product Solution and Service
3.7 Date of Enter into Ophthalmic Therapeutic Drugs Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Ophthalmic Therapeutic Drugs Breakdown Data by Type
4.1 Global Ophthalmic Therapeutic Drugs Historic Market Size by Type (2016-2021)
4.2 Global Ophthalmic Therapeutic Drugs Forecasted Market Size by Type (2022-2027)

5 Ophthalmic Therapeutic Drugs Breakdown Data by Application
5.1 Global Ophthalmic Therapeutic Drugs Historic Market Size by Application (2016-2021)
5.2 Global Ophthalmic Therapeutic Drugs Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Ophthalmic Therapeutic Drugs Market Size (2016-2027)
6.2 North America Ophthalmic Therapeutic Drugs Market Size by Type
6.2.1 North America Ophthalmic Therapeutic Drugs Market Size by Type (2016-2021)
6.2.2 North America Ophthalmic Therapeutic Drugs Market Size by Type (2022-2027)
6.2.3 North America Ophthalmic Therapeutic Drugs Market Size by Type (2016-2027)
6.3 North America Ophthalmic Therapeutic Drugs Market Size by Application
6.3.1 North America Ophthalmic Therapeutic Drugs Market Size by Application (2016-2021)
6.3.2 North America Ophthalmic Therapeutic Drugs Market Size by Application (2022-2027)
6.3.3 North America Ophthalmic Therapeutic Drugs Market Size by Application (2016-2027)
6.4 North America Ophthalmic Therapeutic Drugs Market Size by Country
6.4.1 North America Ophthalmic Therapeutic Drugs Market Size by Country (2016-2021)
6.4.2 North America Ophthalmic Therapeutic Drugs Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada

7 Europe
7.1 Europe Ophthalmic Therapeutic Drugs Market Size (2016-2027)
7.2 Europe Ophthalmic Therapeutic Drugs Market Size by Type
7.2.1 Europe Ophthalmic Therapeutic Drugs Market Size by Type (2016-2021)
7.2.2 Europe Ophthalmic Therapeutic Drugs Market Size by Type (2022-2027)
7.2.3 Europe Ophthalmic Therapeutic Drugs Market Size by Type (2016-2027)
7.3 Europe Ophthalmic Therapeutic Drugs Market Size by Application
7.3.1 Europe Ophthalmic Therapeutic Drugs Market Size by Application (2016-2021)
7.3.2 Europe Ophthalmic Therapeutic Drugs Market Size by Application (2022-2027)
7.3.3 Europe Ophthalmic Therapeutic Drugs Market Size by Application (2016-2027)
7.4 Europe Ophthalmic Therapeutic Drugs Market Size by Country
7.4.1 Europe Ophthalmic Therapeutic Drugs Market Size by Country (2016-2021)
7.4.2 Europe Ophthalmic Therapeutic Drugs Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Ophthalmic Therapeutic Drugs Market Size (2016-2027)
8.2 Asia-Pacific Ophthalmic Therapeutic Drugs Market Size by Type
8.2.1 Asia-Pacific Ophthalmic Therapeutic Drugs Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Ophthalmic Therapeutic Drugs Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Ophthalmic Therapeutic Drugs Market Size by Type (2016-2027)
8.3 Asia-Pacific Ophthalmic Therapeutic Drugs Market Size by Application
8.3.1 Asia-Pacific Ophthalmic Therapeutic Drugs Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Ophthalmic Therapeutic Drugs Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Ophthalmic Therapeutic Drugs Market Size by Application (2016-2027)
8.4 Asia-Pacific Ophthalmic Therapeutic Drugs Market Size by Region
8.4.1 Asia-Pacific Ophthalmic Therapeutic Drugs Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Ophthalmic Therapeutic Drugs Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Ophthalmic Therapeutic Drugs Market Size (2016-2027)
9.2 Latin America Ophthalmic Therapeutic Drugs Market Size by Type
9.2.1 Latin America Ophthalmic Therapeutic Drugs Market Size by Type (2016-2021)
9.2.2 Latin America Ophthalmic Therapeutic Drugs Market Size by Type (2022-2027)
9.2.3 Latin America Ophthalmic Therapeutic Drugs Market Size by Type (2016-2027)
9.3 Latin America Ophthalmic Therapeutic Drugs Market Size by Application
9.3.1 Latin America Ophthalmic Therapeutic Drugs Market Size by Application (2016-2021)
9.3.2 Latin America Ophthalmic Therapeutic Drugs Market Size by Application (2022-2027)
9.3.3 Latin America Ophthalmic Therapeutic Drugs Market Size by Application (2016-2027)
9.4 Latin America Ophthalmic Therapeutic Drugs Market Size by Country
9.4.1 Latin America Ophthalmic Therapeutic Drugs Market Size by Country (2016-2021)
9.4.2 Latin America Ophthalmic Therapeutic Drugs Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Ophthalmic Therapeutic Drugs Market Size (2016-2027)
10.2 Middle East & Africa Ophthalmic Therapeutic Drugs Market Size by Type
10.2.1 Middle East & Africa Ophthalmic Therapeutic Drugs Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Ophthalmic Therapeutic Drugs Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Ophthalmic Therapeutic Drugs Market Size by Type (2016-2027)
10.3 Middle East & Africa Ophthalmic Therapeutic Drugs Market Size by Application
10.3.1 Middle East & Africa Ophthalmic Therapeutic Drugs Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Ophthalmic Therapeutic Drugs Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Ophthalmic Therapeutic Drugs Market Size by Application (2016-2027)
10.4 Middle East & Africa Ophthalmic Therapeutic Drugs Market Size by Country
10.4.1 Middle East & Africa Ophthalmic Therapeutic Drugs Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Ophthalmic Therapeutic Drugs Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Bayer
11.1.1 Bayer Company Details
11.1.2 Bayer Business Overview
11.1.3 Bayer Ophthalmic Therapeutic Drugs Introduction
11.1.4 Bayer Revenue in Ophthalmic Therapeutic Drugs Business (2016-2021)
11.1.5 Bayer Recent Development
11.2 Pfizer
11.2.1 Pfizer Company Details
11.2.2 Pfizer Business Overview
11.2.3 Pfizer Ophthalmic Therapeutic Drugs Introduction
11.2.4 Pfizer Revenue in Ophthalmic Therapeutic Drugs Business (2016-2021)
11.2.5 Pfizer Recent Development
11.3 Novartis
11.3.1 Novartis Company Details
11.3.2 Novartis Business Overview
11.3.3 Novartis Ophthalmic Therapeutic Drugs Introduction
11.3.4 Novartis Revenue in Ophthalmic Therapeutic Drugs Business (2016-2021)
11.3.5 Novartis Recent Development
11.4 ALLERGAN
11.4.1 ALLERGAN Company Details
11.4.2 ALLERGAN Business Overview
11.4.3 ALLERGAN Ophthalmic Therapeutic Drugs Introduction
11.4.4 ALLERGAN Revenue in Ophthalmic Therapeutic Drugs Business (2016-2021)
11.4.5 ALLERGAN Recent Development
11.5 Aerie Pharmaceuticals
11.5.1 Aerie Pharmaceuticals Company Details
11.5.2 Aerie Pharmaceuticals Business Overview
11.5.3 Aerie Pharmaceuticals Ophthalmic Therapeutic Drugs Introduction
11.5.4 Aerie Pharmaceuticals Revenue in Ophthalmic Therapeutic Drugs Business (2016-2021)
11.5.5 Aerie Pharmaceuticals Recent Development
11.6 Bausch Health
11.6.1 Bausch Health Company Details
11.6.2 Bausch Health Business Overview
11.6.3 Bausch Health Ophthalmic Therapeutic Drugs Introduction
11.6.4 Bausch Health Revenue in Ophthalmic Therapeutic Drugs Business (2016-2021)
11.6.5 Bausch Health Recent Development
11.7 Genentech
11.7.1 Genentech Company Details
11.7.2 Genentech Business Overview
11.7.3 Genentech Ophthalmic Therapeutic Drugs Introduction
11.7.4 Genentech Revenue in Ophthalmic Therapeutic Drugs Business (2016-2021)
11.7.5 Genentech Recent Development
11.8 Regeneron Pharmaceuticals
11.8.1 Regeneron Pharmaceuticals Company Details
11.8.2 Regeneron Pharmaceuticals Business Overview
11.8.3 Regeneron Pharmaceuticals Ophthalmic Therapeutic Drugs Introduction
11.8.4 Regeneron Pharmaceuticals Revenue in Ophthalmic Therapeutic Drugs Business (2016-2021)
11.8.5 Regeneron Pharmaceuticals Recent Development
11.9 Takeda
11.9.1 Takeda Company Details
11.9.2 Takeda Business Overview
11.9.3 Takeda Ophthalmic Therapeutic Drugs Introduction
11.9.4 Takeda Revenue in Ophthalmic Therapeutic Drugs Business (2016-2021)
11.9.5 Takeda Recent Development
11.10 Santen Pharmaceutical
11.10.1 Santen Pharmaceutical Company Details
11.10.2 Santen Pharmaceutical Business Overview
11.10.3 Santen Pharmaceutical Ophthalmic Therapeutic Drugs Introduction
11.10.4 Santen Pharmaceutical Revenue in Ophthalmic Therapeutic Drugs Business (2016-2021)
11.10.5 Santen Pharmaceutical Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Ophthalmic Therapeutic Drugs Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Anti-inflammatory Drugs
Table 3. Key Players of Anti-infective Drugs
Table 4. Key Players of Anti-glaucoma Drugs
Table 5. Key Players of Anti-allergy Drugs
Table 6. Key Players of Anti-VEGF Agents
Table 7. Key Players of Others
Table 8. Global Ophthalmic Therapeutic Drugs Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 9. Global Ophthalmic Therapeutic Drugs Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 10. Global Ophthalmic Therapeutic Drugs Market Size by Regions (2016-2021) & (US$ Million)
Table 11. Global Ophthalmic Therapeutic Drugs Market Share by Regions (2016-2021)
Table 12. Global Ophthalmic Therapeutic Drugs Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 13. Global Ophthalmic Therapeutic Drugs Market Share by Regions (2022-2027)
Table 14. Ophthalmic Therapeutic Drugs Market Trends
Table 15. Ophthalmic Therapeutic Drugs Market Drivers
Table 16. Ophthalmic Therapeutic Drugs Market Challenges
Table 17. Ophthalmic Therapeutic Drugs Market Restraints
Table 18. Global Ophthalmic Therapeutic Drugs Revenue by Players (2016-2021) & (US$ Million)
Table 19. Global Ophthalmic Therapeutic Drugs Market Share by Players (2016-2021)
Table 20. Global Top Ophthalmic Therapeutic Drugs Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Ophthalmic Therapeutic Drugs as of 2020)
Table 21. Ranking of Global Top Ophthalmic Therapeutic Drugs Companies by Revenue (US$ Million) in 2020
Table 22. Global 5 Largest Players Market Share by Ophthalmic Therapeutic Drugs Revenue (CR5 and HHI) & (2016-2021)
Table 23. Key Players Headquarters and Area Served
Table 24. Key Players Ophthalmic Therapeutic Drugs Product Solution and Service
Table 25. Date of Enter into Ophthalmic Therapeutic Drugs Market
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Ophthalmic Therapeutic Drugs Market Size by Type (2016-2021) (US$ Million)
Table 28. Global Ophthalmic Therapeutic Drugs Revenue Market Share by Type (2016-2021)
Table 29. Global Ophthalmic Therapeutic Drugs Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 30. Global Ophthalmic Therapeutic Drugs Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 31. Global Ophthalmic Therapeutic Drugs Market Size Share by Application (2016-2021) & (US$ Million)
Table 32. Global Ophthalmic Therapeutic Drugs Revenue Market Share by Application (2016-2021)
Table 33. Global Ophthalmic Therapeutic Drugs Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 34. Global Ophthalmic Therapeutic Drugs Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 35. North America Ophthalmic Therapeutic Drugs Market Size by Type (2016-2021) (US$ Million)
Table 36. North America Ophthalmic Therapeutic Drugs Market Size by Type (2022-2027) & (US$ Million)
Table 37. North America Ophthalmic Therapeutic Drugs Market Size by Application (2016-2021) (US$ Million)
Table 38. North America Ophthalmic Therapeutic Drugs Market Size by Application (2022-2027) & (US$ Million)
Table 39. North America Ophthalmic Therapeutic Drugs Market Size by Country (2016-2021) & (US$ Million)
Table 40. North America Ophthalmic Therapeutic Drugs Market Size by Country (2022-2027) & (US$ Million)
Table 41. Europe Ophthalmic Therapeutic Drugs Market Size by Type (2016-2021) (US$ Million)
Table 42. Europe Ophthalmic Therapeutic Drugs Market Size by Type (2022-2027) & (US$ Million)
Table 43. Europe Ophthalmic Therapeutic Drugs Market Size by Application (2016-2021) (US$ Million)
Table 44. Europe Ophthalmic Therapeutic Drugs Market Size by Application (2022-2027) & (US$ Million)
Table 45. Europe Ophthalmic Therapeutic Drugs Market Size by Country (2016-2021) & (US$ Million)
Table 46. Europe Ophthalmic Therapeutic Drugs Market Size by Country (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Ophthalmic Therapeutic Drugs Market Size by Type (2016-2021) (US$ Million)
Table 48. Asia-Pacific Ophthalmic Therapeutic Drugs Market Size by Type (2022-2027) & (US$ Million)
Table 49. Asia-Pacific Ophthalmic Therapeutic Drugs Market Size by Application (2016-2021) (US$ Million)
Table 50. Asia-Pacific Ophthalmic Therapeutic Drugs Market Size by Application (2022-2027) & (US$ Million)
Table 51. Asia-Pacific Ophthalmic Therapeutic Drugs Market Size by Region (2016-2021) & (US$ Million)
Table 52. Asia-Pacific Ophthalmic Therapeutic Drugs Market Size by Region (2022-2027) & (US$ Million)
Table 53. Latin America Ophthalmic Therapeutic Drugs Market Size by Type (2016-2021) (US$ Million)
Table 54. Latin America Ophthalmic Therapeutic Drugs Market Size by Type (2022-2027) & (US$ Million)
Table 55. Latin America Ophthalmic Therapeutic Drugs Market Size by Application (2016-2021) (US$ Million)
Table 56. Latin America Ophthalmic Therapeutic Drugs Market Size by Application (2022-2027) & (US$ Million)
Table 57. Latin America Ophthalmic Therapeutic Drugs Market Size by Country (2016-2021) & (US$ Million)
Table 58. Latin America Ophthalmic Therapeutic Drugs Market Size by Country (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Ophthalmic Therapeutic Drugs Market Size by Type (2016-2021) (US$ Million)
Table 60. Middle East & Africa Ophthalmic Therapeutic Drugs Market Size by Type (2022-2027) & (US$ Million)
Table 61. Middle East & Africa Ophthalmic Therapeutic Drugs Market Size by Application (2016-2021) (US$ Million)
Table 62. Middle East & Africa Ophthalmic Therapeutic Drugs Market Size by Application (2022-2027) & (US$ Million)
Table 63. Middle East & Africa Ophthalmic Therapeutic Drugs Market Size by Country (2016-2021) & (US$ Million)
Table 64. Middle East & Africa Ophthalmic Therapeutic Drugs Market Size by Country (2022-2027) & (US$ Million)
Table 65. Bayer Company Details
Table 66. Bayer Business Overview
Table 67. Bayer Ophthalmic Therapeutic Drugs Product
Table 68. Bayer Revenue in Ophthalmic Therapeutic Drugs Business (2016-2021) & (US$ Million)
Table 69. Bayer Recent Development
Table 70. Pfizer Company Details
Table 71. Pfizer Business Overview
Table 72. Pfizer Ophthalmic Therapeutic Drugs Product
Table 73. Pfizer Revenue in Ophthalmic Therapeutic Drugs Business (2016-2021) & (US$ Million)
Table 74. Pfizer Recent Development
Table 75. Novartis Company Details
Table 76. Novartis Business Overview
Table 77. Novartis Ophthalmic Therapeutic Drugs Product
Table 78. Novartis Revenue in Ophthalmic Therapeutic Drugs Business (2016-2021) & (US$ Million)
Table 79. Novartis Recent Development
Table 80. ALLERGAN Company Details
Table 81. ALLERGAN Business Overview
Table 82. ALLERGAN Ophthalmic Therapeutic Drugs Product
Table 83. ALLERGAN Revenue in Ophthalmic Therapeutic Drugs Business (2016-2021) & (US$ Million)
Table 84. ALLERGAN Recent Development
Table 85. Aerie Pharmaceuticals Company Details
Table 86. Aerie Pharmaceuticals Business Overview
Table 87. Aerie Pharmaceuticals Ophthalmic Therapeutic Drugs Product
Table 88. Aerie Pharmaceuticals Revenue in Ophthalmic Therapeutic Drugs Business (2016-2021) & (US$ Million)
Table 89. Aerie Pharmaceuticals Recent Development
Table 90. Bausch Health Company Details
Table 91. Bausch Health Business Overview
Table 92. Bausch Health Ophthalmic Therapeutic Drugs Product
Table 93. Bausch Health Revenue in Ophthalmic Therapeutic Drugs Business (2016-2021) & (US$ Million)
Table 94. Bausch Health Recent Development
Table 95. Genentech Company Details
Table 96. Genentech Business Overview
Table 97. Genentech Ophthalmic Therapeutic Drugs Product
Table 98. Genentech Revenue in Ophthalmic Therapeutic Drugs Business (2016-2021) & (US$ Million)
Table 99. Genentech Recent Development
Table 100. Regeneron Pharmaceuticals Company Details
Table 101. Regeneron Pharmaceuticals Business Overview
Table 102. Regeneron Pharmaceuticals Revenue in Ophthalmic Therapeutic Drugs Business (2016-2021) & (US$ Million)
Table 103. Regeneron Pharmaceuticals Recent Development
Table 104. Takeda Company Details
Table 105. Takeda Business Overview
Table 106. Takeda Ophthalmic Therapeutic Drugs Product
Table 107. Takeda Revenue in Ophthalmic Therapeutic Drugs Business (2016-2021) & (US$ Million)
Table 108. Takeda Recent Development
Table 109. Santen Pharmaceutical Company Details
Table 110. Santen Pharmaceutical Business Overview
Table 111. Santen Pharmaceutical Ophthalmic Therapeutic Drugs Product
Table 112. Santen Pharmaceutical Revenue in Ophthalmic Therapeutic Drugs Business (2016-2021) & (US$ Million)
Table 113. Santen Pharmaceutical Recent Development
Table 114. Research Programs/Design for This Report
Table 115. Key Data Information from Secondary Sources
Table 116. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Ophthalmic Therapeutic Drugs Market Share by Type: 2020 VS 2027
Figure 2. Anti-inflammatory Drugs Features
Figure 3. Anti-infective Drugs Features
Figure 4. Anti-glaucoma Drugs Features
Figure 5. Anti-allergy Drugs Features
Figure 6. Anti-VEGF Agents Features
Figure 7. Others Features
Figure 8. Global Ophthalmic Therapeutic Drugs Market Share by Application: 2020 VS 2027
Figure 9. Hospital Pharmacies Case Studies
Figure 10. Online Pharmacies Case Studies
Figure 11. Independent Pharmacies & Drug Stores Case Studies
Figure 12. Ophthalmic Therapeutic Drugs Report Years Considered
Figure 13. Global Ophthalmic Therapeutic Drugs Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 14. Global Ophthalmic Therapeutic Drugs Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 15. Global Ophthalmic Therapeutic Drugs Market Share by Regions: 2020 VS 2027
Figure 16. Global Ophthalmic Therapeutic Drugs Market Share by Regions (2022-2027)
Figure 17. Global Ophthalmic Therapeutic Drugs Market Share by Players in 2020
Figure 18. Global Top Ophthalmic Therapeutic Drugs Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Ophthalmic Therapeutic Drugs as of 2020
Figure 19. The Top 10 and 5 Players Market Share by Ophthalmic Therapeutic Drugs Revenue in 2020
Figure 20. Global Ophthalmic Therapeutic Drugs Revenue Market Share by Type (2016-2021)
Figure 21. Global Ophthalmic Therapeutic Drugs Revenue Market Share by Type (2022-2027)
Figure 22. North America Ophthalmic Therapeutic Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 23. North America Ophthalmic Therapeutic Drugs Market Share by Type (2016-2027)
Figure 24. North America Ophthalmic Therapeutic Drugs Market Share by Application (2016-2027)
Figure 25. North America Ophthalmic Therapeutic Drugs Market Share by Country (2016-2027)
Figure 26. United States Ophthalmic Therapeutic Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Canada Ophthalmic Therapeutic Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 28. Europe Ophthalmic Therapeutic Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 29. Europe Ophthalmic Therapeutic Drugs Market Share by Type (2016-2027)
Figure 30. Europe Ophthalmic Therapeutic Drugs Market Share by Application (2016-2027)
Figure 31. Europe Ophthalmic Therapeutic Drugs Market Share by Country (2016-2027)
Figure 32. Germany Ophthalmic Therapeutic Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. France Ophthalmic Therapeutic Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. U.K. Ophthalmic Therapeutic Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Italy Ophthalmic Therapeutic Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Russia Ophthalmic Therapeutic Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Nordic Ophthalmic Therapeutic Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. Asia-Pacific Ophthalmic Therapeutic Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. Asia-Pacific Ophthalmic Therapeutic Drugs Market Share by Type (2016-2027)
Figure 40. Asia-Pacific Ophthalmic Therapeutic Drugs Market Share by Application (2016-2027)
Figure 41. Asia-Pacific Ophthalmic Therapeutic Drugs Market Share by Region (2016-2027)
Figure 42. China Ophthalmic Therapeutic Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Japan Ophthalmic Therapeutic Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. South Korea Ophthalmic Therapeutic Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Southeast Asia Ophthalmic Therapeutic Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. India Ophthalmic Therapeutic Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Australia Ophthalmic Therapeutic Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 48. Latin America Ophthalmic Therapeutic Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. Latin America Ophthalmic Therapeutic Drugs Market Share by Type (2016-2027)
Figure 50. Latin America Ophthalmic Therapeutic Drugs Market Share by Application (2016-2027)
Figure 51. Latin America Ophthalmic Therapeutic Drugs Market Share by Country (2016-2027)
Figure 52. Mexico Ophthalmic Therapeutic Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Brazil Ophthalmic Therapeutic Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 54. Middle East & Africa Ophthalmic Therapeutic Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 55. Middle East & Africa Ophthalmic Therapeutic Drugs Market Share by Type (2016-2027)
Figure 56. Middle East & Africa Ophthalmic Therapeutic Drugs Market Share by Application (2016-2027)
Figure 57. Middle East & Africa Ophthalmic Therapeutic Drugs Market Share by Country (2016-2027)
Figure 58. Turkey Ophthalmic Therapeutic Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. Saudi Arabia Ophthalmic Therapeutic Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 60. UAE Ophthalmic Therapeutic Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 61. Bayer Revenue Growth Rate in Ophthalmic Therapeutic Drugs Business (2016-2021)
Figure 62. Pfizer Revenue Growth Rate in Ophthalmic Therapeutic Drugs Business (2016-2021)
Figure 63. Novartis Revenue Growth Rate in Ophthalmic Therapeutic Drugs Business (2016-2021)
Figure 64. ALLERGAN Revenue Growth Rate in Ophthalmic Therapeutic Drugs Business (2016-2021)
Figure 65. Aerie Pharmaceuticals Revenue Growth Rate in Ophthalmic Therapeutic Drugs Business (2016-2021)
Figure 66. Bausch Health Revenue Growth Rate in Ophthalmic Therapeutic Drugs Business (2016-2021)
Figure 67. Genentech Revenue Growth Rate in Ophthalmic Therapeutic Drugs Business (2016-2021)
Figure 68. Regeneron Pharmaceuticals Revenue Growth Rate in Ophthalmic Therapeutic Drugs Business (2016-2021)
Figure 69. Takeda Revenue Growth Rate in Ophthalmic Therapeutic Drugs Business (2016-2021)
Figure 70. Santen Pharmaceutical Revenue Growth Rate in Ophthalmic Therapeutic Drugs Business (2016-2021)
Figure 71. Bottom-up and Top-down Approaches for This Report
Figure 72. Data Triangulation
Figure 73. Key Executives Interviewed

---